These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9609259)

  • 1. Practical strategies for hormone replacement therapy and risk of venous thromboembolism.
    Greer IA
    Br J Obstet Gynaecol; 1998 Apr; 105(4):376-9. PubMed ID: 9609259
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H; de Moerloose P; Campana A
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormone replacement therapy in menopause, hemostasis and thromboembolic risk].
    Levesque H; Cailleux N; Courtois H
    J Mal Vasc; 1994; 19(2):93-7. PubMed ID: 8077869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of hormone replacement treatment of menopause on the risk of venous thromboembolic disease].
    Thery C; Prat A; Asseman P; Bauchart JJ; Michon P; Lesenne M; Jude B
    Therapie; 1997; 52(3):165-8. PubMed ID: 9366099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations].
    van den Brûle F; Gaspard U
    J Pharm Belg; 2004; 59(1):38-40. PubMed ID: 15129579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of thrombophilia.
    García de Frutos P
    Thromb Haemost; 2007 Sep; 98(3):485-7. PubMed ID: 17849035
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism.
    Levi M; Middeldorp S; Büller HR
    Cardiovasc Res; 1999 Jan; 41(1):21-4. PubMed ID: 10325950
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thrombophilic disorders in venous thromboembolism. The clinical perspective].
    Schmidt B; Schellong S
    Med Klin (Munich); 2003 Mar; 98(3):133-9. PubMed ID: 12647087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of venous thromboembolism during postmenopausal hormone therapy].
    Pedersen AT; Ottesen B
    Ugeskr Laeger; 1996 Nov; 158(48):6923-4. PubMed ID: 8984757
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe.
    Varas-Lorenzo C; García-Rodríguez LA; Cattaruzzi C; Troncon MG; Agostinis L; Perez-Gutthann S
    Am J Epidemiol; 1998 Feb; 147(4):387-90. PubMed ID: 9508106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral arterial disease and thrombophilia.
    Müller-Kolck U
    Vasa; 2008 May; 37(2):189; author reply 190-2. PubMed ID: 18622971
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone replacement therapy and venous thromboembolism.
    Greer IA; Walker ID
    Climacteric; 1999 Sep; 2(3):224-31. PubMed ID: 11910601
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence-based indications for thrombophilia screening.
    Lindhoff-Last E; Luxembourg B
    Vasa; 2008 Feb; 37(1):19-30. PubMed ID: 18512539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.
    Rexrode KM; Manson JE
    Circulation; 2007 Feb; 115(7):820-2. PubMed ID: 17309929
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic influence of hormone-replacement therapy on venous thromboembolism.
    Sumino H; Ichikawa S; Kumakura H; Takayama Y; Kurabayashi M
    Lancet; 2003 Oct; 362(9391):1242. PubMed ID: 14568759
    [No Abstract]   [Full Text] [Related]  

  • 16. Venous thrombo-embolism and hormone replacement therapy.
    Whitehead M; Godfree V
    Baillieres Clin Obstet Gynaecol; 1997 Sep; 11(3):587-99. PubMed ID: 9488793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy and thromboembolic disease.
    Battaglioli T; Martinelli I
    Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study.
    Pérez Gutthann S; García Rodríguez LA; Castellsague J; Duque Oliart A
    BMJ; 1997 Mar; 314(7083):796-800. PubMed ID: 9081000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postmenopausal hormonal substitution and risk of venous thromboembolism. Need for prospective, randomized trials].
    Arnesen H; Qvigstad E
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4064. PubMed ID: 9441436
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormone therapy and cardiovascular risk].
    Wütschert R; Cirafici P
    Praxis (Bern 1994); 2000 Jun; 89(25-26):1090-7. PubMed ID: 11367591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.